I know…just wondering what could be under wraps.
The interviewer started with “flagship drug” - well that is standard terminology and then Dr.T responded with “lead asset” which is another industry term but given R&D work who knows what’s cooking?
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene, page-40
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.81 |
Change
-0.030(1.63%) |
Mkt cap ! $307.6M | |||
| Open | High | Low | Value | Volume |
| $1.85 | $1.94 | $1.77 | $230.8K | 124.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15405 | $1.79 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.85 | 1750 | 1 |
View Market Depth
| Last trade - 16.10pm 25/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |